Risk

Selling outside of app stores forces users to deactivate a crucial safeguard which would otherwise prevent the download of potentially malicious apps onto their mobile device, contends Samuel Bakken, senior product marketing manager for OneSpan.

Moody's Investors Service downgraded JPMorgan Chase's prime jumbo mortgage originator assessment to its second-highest rating, citing the bank's growing reliance on correspondents with delegated underwriting authority and shortcomings in its technology infrastructure.

State Treasurer John Chiang says that Wells Fargo is keeping patterns of abuse hidden from view by resolving customer disputes through private arbitration.

ATM jackpotting is a growing threat throughout the United States, with thieves attempting to attack the most vulnerable locations possible, according to Paul Albright, executive vice president of Outsource ATM.

The industry’s profit was $60.2 billion, a more than 7% increase from the previous record set in the first quarter and a 25% leap from a year earlier, the agency said in its quarterly report on the industry's health.

A solid software development life cycle method — a way of organizing the work of a software development team — can mean the difference between getting ahead in payments or falling behind, according to Chet Culver, director of application development at CardConnect.

One expert offers credit union leaders "the best defense against risk" and lessons from previous economic crises.

Even as the payments landscape has become increasingly complicated and convoluted over the past several years, many industry players have not kept pace with their payments testing methods or tools, writes Steve Gilde, director of global product marketing for Paragon Application Systems.

IBM claims that by monitoring customer behavior first and foremost, banks can make suspicious activity reporting far more accurate.

It's a fickle industry, given the uncertainty over the Affordable Care Act and government reimbursements, but opportunities in lending to medical practices and device manufacturers make it hard to resist, bankers say.